Faculty Opinions recommendation of Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity.

Author(s):  
Remy Bosselut
Cell ◽  
2012 ◽  
Vol 149 (2) ◽  
pp. 467-482 ◽  
Author(s):  
Jingli A. Zhang ◽  
Ali Mortazavi ◽  
Brian A. Williams ◽  
Barbara J. Wold ◽  
Ellen V. Rothenberg

2021 ◽  
Vol 21 (4) ◽  
pp. 206-206
Author(s):  
Felix Clemens Richter ◽  
Alexander J. Clarke

2013 ◽  
Vol 9 (5) ◽  
pp. e1003303 ◽  
Author(s):  
Julius Clemence R. Hafalla ◽  
Karolis Bauza ◽  
Johannes Friesen ◽  
Gloria Gonzalez-Aseguinolaza ◽  
Adrian V. S. Hill ◽  
...  

2007 ◽  
Vol 8 (2) ◽  
pp. 119-120 ◽  
Author(s):  
Harinder Singh
Keyword(s):  
T Cell ◽  

Author(s):  
Felix J. Hartmann ◽  
Dunja Mrdjen ◽  
Erin McCaffrey ◽  
David R. Glass ◽  
Noah F. Greenwald ◽  
...  

SummaryCellular metabolism regulates immune cell activation, differentiation and effector functions to the extent that its perturbation can augment immune responses. However, the analytical technologies available to study cellular metabolism lack single-cell resolution, obscuring metabolic heterogeneity and its connection to immune phenotype and function. To that end, we utilized high-dimensional, antibody-based technologies to simultaneously quantify the single-cell metabolic regulome in combination with phenotypic identity. Mass cytometry (CyTOF)-based application of this approach to early human T cell activation enabled the comprehensive reconstruction of the coordinated metabolic remodeling of naïve CD8+ T cells and aligned with conventional bulk assays for glycolysis and oxidative phosphorylation. Extending this analysis to a variety of tissue-resident immune cells revealed tissue-restricted metabolic states of human cytotoxic T cells, including metabolically repressed subsets that expressed CD39 and PD1 and that were enriched in colorectal carcinoma versus healthy adjacent tissue. Finally, combining this approach with multiplexed ion beam imaging by time-of-flight (MIBI-TOF) demonstrated the existence of spatially enriched metabolic neighborhoods, independent of cell identity and additionally revealed exclusion of metabolically repressed cytotoxic T cell states from the tumor-immune boundary in human colorectal carcinoma. Overall, we provide an approach that permits the robust approximation of metabolic states in individual cells along with multimodal analysis of cell identity and functional characteristics that can be applied to human clinical samples to study cellular metabolism how it may be perturbed to affect immunological outcomes.


2018 ◽  
Vol 115 (26) ◽  
pp. 6727-6732 ◽  
Author(s):  
Caralynn M. Wilczewski ◽  
Austin J. Hepperla ◽  
Takashi Shimbo ◽  
Lauren Wasson ◽  
Zachary L. Robbe ◽  
...  

Cardiac development relies on proper cardiomyocyte differentiation, including expression and assembly of cell-type-specific actomyosin subunits into a functional cardiac sarcomere. Control of this process involves not only promoting expression of cardiac sarcomere subunits but also repressing expression of noncardiac myofibril paralogs. This level of transcriptional control requires broadly expressed multiprotein machines that modify and remodel the chromatin landscape to restrict transcription machinery access. Prominent among these is the nucleosome remodeling and deacetylase (NuRD) complex, which includes the catalytic core subunit CHD4. Here, we demonstrate that direct CHD4-mediated repression of skeletal and smooth muscle myofibril isoforms is required for normal cardiac sarcomere formation, function, and embryonic survival early in gestation. Through transcriptomic and genome-wide analyses of CHD4 localization, we identified unique CHD4 binding sites in smooth muscle myosin heavy chain, fast skeletal α-actin, and the fast skeletal troponin complex genes. We further demonstrate that in the absence of CHD4, cardiomyocytes in the developing heart form a hybrid muscle cell that contains cardiac, skeletal, and smooth muscle myofibril components. These misexpressed paralogs intercalate into the nascent cardiac sarcomere to disrupt sarcomere formation and cause impaired cardiac function in utero. These results demonstrate the genomic and physiological requirements for CHD4 in mammalian cardiac development.


Cell ◽  
2019 ◽  
Vol 178 (4) ◽  
pp. 1016-1028.e13 ◽  
Author(s):  
Tomasz Kula ◽  
Mohammad H. Dezfulian ◽  
Charlotte I. Wang ◽  
Nouran S. Abdelfattah ◽  
Zachary C. Hartman ◽  
...  
Keyword(s):  
T Cell ◽  

Blood ◽  
2020 ◽  
Author(s):  
Tasneem Khanam ◽  
Sarah Sandmann ◽  
Jochen Seggewiss ◽  
Charlotte Marie Ruether ◽  
Martin Zimmermann ◽  
...  

T-cell lymphoblastic lymphoma (T-LBL) is a heterogeneous malignancy of lymphoblasts committed to T-cell lineage. Dismal outcomes (15-30%) in case of T-LBL relapses warrants for establishing risk-based treatment in future. This is a first comprehensive, systematic, integrated genome-wide analysis including relapse cases aimed towards identifying molecular markers of prognostic relevance for T-LBL. NOTCH1 was identified as putative driver for T-LBL. Activated NOTCH/PI3K-AKT signaling axis and alterations in cell cycle regulators constitutes the core oncogenic program for T-LBL. Mutated KMT2D was identified as a prognostic marker. The cumulative incidence of relapse was 47±17% in patients with KMT2D mutations compared with 14±3% in KMT2D wildtype. Structural analysis of the mutated domains of KMT2D revealed plausible impact on the structure and functional consequences. These findings provide new insights into the pathogenesis of T-LBL including high translational potential. The ongoing trial LBL 2018 (NCT04043494) allows prospective validation and subsequent fine-tuning of the stratification criteria for T-LBL risk groups to improve survival of the pediatric patients.


Sign in / Sign up

Export Citation Format

Share Document